Delivery Order SPE2DB22D1002-SPE2DB24FKSY6
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Victoza 3-Pak 18 mg/3 ml pen, a medication used to treat diabetes. The delivery order contract is valued at $6,404.26 and has a completion date of October 6, 2023. The contract is a firm fixed-price, delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,847.54, is a delivery order for the supply of Victoza 3-Pak 18 mg/3 ml Pen 3 ml, a medication used for the treatment of type 2 diabetes. The contract has an ultimate completion date of November 16, 2023 and is designated as a firm fixed-price contract. No set-aside requirements were used...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,914.72 delivery order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medical product used for diabetes management. The contract has an ultimate completion date of June 30, 2022 and is a firm fixed-price agreement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.32 delivery order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of August 31, 2022 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Victoza 3-Pak 18 mg/3 ml pen. The contract has a ceiling value of $1,638.76 and a completion date of November 8, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,056.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Victoza 3-Pak 18 mg/3 ml Pen 3 ml, a medication used to manage diabetes. This award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00,...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $2,154.27, is for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the...
- This federal contract award, valued at $16,895.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Victoza 3-Pak 18 mg/3 ml pen 3 ml, a medication used to manage diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,935.38 firm fixed-price delivery order contract is for the supply of the diabetes medication Victoza 3-Pak 18 mg/3 mL pens. The contract has an ultimate completion date of May 6, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.12 fixed-price delivery order is for the procurement of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKSY6Delivery Order
This federal contract award, valued at $1,361.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Victoza 3-Pak 18 mg/3 ml pen, a medication used for diabetes management. This is a firm fixed-price delivery order contract with an ultimate completion date of October 17, 2023. The contract is not designated with a set-aside, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/16/23 |